Preparation method of polygonatum kingianum metaplasm with anti-inflammatory effect
By screening the excellent active strains and combined with the diamondine polygonatum extract, the penis of the diamondine polygonatum was prepared, and the antagonism caused by improper combination of plant extracts and strains was solved, and the efficient anti-inflammatory and immune regulation effect was achieved, which significantly improved the reproduction. Free radical scavenging and anti-inflammatory ability of the formula.
Patent Information
- Application Number
- CN202411154857.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-15
AI Technical Summary
In the prior art, improper combination of plant extracts and strains may lead to antagonism, difficult to effectively improve the balance of intestinal microecologic groups and improve the body's immunity, and lack efficient anti-inflammatory agents.
Three strains with excellent activity were screened from common food source fermentation bacteria, combined with vinyl polygonatum extract, and prepared anti-inflammatory posterior vinyl polygonatum. Through ultrasonic extraction of 60°C and the preparation of cell-free supernatant, it formed Yunnan Polygonatum epiphytes.
The DPPH radical scavenging ability, ABTS cation radical scavenging ability, inhibitory effect on NO and phagocytosis ability of the complexes has been enhanced, and the functional activity has been significantly improved. Carboxylic acids and their derivatives, fatty acyls, benzene and their derivatives are Metabolites such as glycerol phospholipids have significant changes.
Smart Images

Figure FT_1 
Figure FT_2 
Figure BDA0005004654540000031
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of high-activity functional foods, and in particular to a method for preparing a Yunnan polygonatum postbiotic with anti-inflammatory effects. Background Art
[0002] Polygonatum is a genus in the Liliaceae family. There are about 50 species in the world, including 31 species in China, which are widely distributed. Its root has a mild and moisturizing property, sweet and light taste, non-toxic and insecticidal, and can replenish qi, stabilize the liver and gallbladder, and moisten the heart and lungs. Modern research has shown that Polygonatum has active ingredients such as polysaccharides, saponins, alkaloids, and flavonoids, and has multiple effects such as improving immunity, anti-oxidation, delaying aging, anti-inflammatory, and anti-tumor. Polygonatum has the characteristics of multiple components, weak effects, and coordinated integration. Its pharmacological effects are the comprehensive effects of multiple components. Yunnan Province is a natural drug source library. There are many varieties of Polygonatum in Yunnan Province. There are 12 species of Polygonatum in the country, and Polygonatum kingianum is often the main one. Polygonatum kingianum is rich in active ingredients such as polysaccharides, saponins, flavonoids, alkaloids, etc., and has good effects in regulating immunity, anti-oxidation, lowering blood sugar, anti-aging, and anti-inflammatory. At present, there are abundant edible microbial strains, including fungi, bacteria, microalgae and actinomycetes. Some of them have excellent metabolic functions and health-care effects and have broad development prospects. Through the continuous screening of new functional strains, the edible microbial strain resources have been greatly enriched. At present, there are related studies on the combined use of plant active substances and strains to improve the efficacy. For example, Sorrenti et al. (Beneficial Effects of Pomegranate Peel Extract and Probiotics on Pre-adipocyte Differentiation) found that the synergistic effect of probiotics and polyphenol-containing pomegranate extracts may affect in vitro fat formation and may help develop new nutritional / probiotic therapies to prevent and treat obesity. However, the immune activation and regulation mechanisms of different strains and plant extracts are different. If the plant extracts and strains are combined appropriately, the purpose of improving the balance of the intestinal microecological community and enhancing the body's immunity can be achieved; if the combination is inappropriate, antagonism may occur. The present invention screens three edible strains with excellent activity from common food-derived fermentation bacteria, compounding their fermentation supernatants with a Polygonatum cyrtonema extract to prepare Polygonatum cyrtonema postbiotics with anti-inflammatory effects, which is of great significance to the development and utilization of Polygonatum cyrtonema resources and the development of postbiotic products. Summary of the invention
[0003] In this regard, the present invention provides a method for preparing a postbiotic from Polygonatum sibiricum with anti-inflammatory effect, the preparation steps comprising:
[0004] (1) Preparation of Yunnan Polygonatum cyrtonema extract: Wash and slice a fresh Yunnan Polygonatum cyrtonema sample, freeze-dry and grind it, and pass it through a 60-mesh sieve; add the sieved powder into an ethanol aqueous solution, and perform ultrasonic extraction at 60° C. After the extraction is completed, filter the solution, take the supernatant, and repeat the above extraction process with the residue, combine the two filtrates, concentrate under reduced pressure, and freeze-dry to obtain the Yunnan Polygonatum cyrtonema extract, which is stored at 2° C. and away from light;
[0005] (2) Preparation of cell-free supernatant: After culturing the strain in a culture medium, the bacterial cells are collected by centrifugation, washed 2 to 3 times with a phosphate buffered saline solution, and then resuspended in a phosphate buffered saline solution and incubated; the bacterial suspension is then centrifuged, filtered through a filter membrane, and the supernatant is collected to obtain a cell-free supernatant;
[0006] (3) The polygonatum cyrtonema extract is compounded with the cell-free supernatant, and the compounded solution is stored at 2° C. to obtain the polygonatum cyrtonema postbiotics.
[0007] Furthermore, in the ethanol aqueous solution, the volume percentage of ethanol is 80%, and the mass ratio of the sieved powder added to the ethanol aqueous solution is sieved powder: ethanol aqueous solution = 1:20.
[0008] Furthermore, ultrasonic extraction is performed at 60° C. for more than 60 min.
[0009] Furthermore, the strain is a 1:1 compound strain of Streptococcus thermophilus and Lactobacillus bulgaricus, or a Monascus ruber strain.
[0010] Furthermore, the bacterial cells were resuspended in phosphate buffered saline at a concentration of 1×10 9 CFU / mL, fungal concentration is 1×10 9 / mL; incubate for 24h.
[0011] Furthermore, filtration was performed using a 0.22 μm filter membrane.
[0012] Furthermore, the compounding ratio of the polygonatum sibiricum extract and the cell-free supernatant is: the polygonatum sibiricum extract and the cell-free supernatant of the culture of Streptococcus thermophilus and Lactobacillus bulgaricus are compounded in a volume ratio of polygonatum sibiricum extract:cell-free supernatant=3:1; the polygonatum sibiricum extract and the cell-free supernatant of the culture of Monascus ruber are compounded in a volume ratio of polygonatum sibiricum extract:cell-free supernatant=2:1.
[0013] The beneficial effects of the present invention are that the DPPH free radical scavenging ability, ABTS cation free radical scavenging ability, NO inhibition and phagocytosis promoting ability of the compound of the present invention are all stronger than those of a single sample. The reason for the enhanced functional activity of the compound may be that significant changes have been found in metabolites in the categories of carboxylic acids and their derivatives, fatty acyl groups, benzene and its derivatives, glycerophospholipids, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 The free radical scavenging ability comparison chart of each sample, wherein: A, DPPH free radical scavenging ability of Yunnan polygonatum extract (A1) and compound (A2); B, ABTS cation free radical scavenging ability of Yunnan polygonatum extract (B1) and compound (B2);
[0015] Figure 2 The figure is a comparison chart of the in vitro anti-inflammatory and immunomodulatory activities of each sample, wherein: A, the effect of the control sample (A1) and the compound (A2) on the NO concentration; B, the effect of the control sample (B1) and the compound (B2) on the phagocytic ability of RAW264.7 cells. DETAILED DESCRIPTION
[0016] The present invention will be further described below in conjunction with the embodiments.
[0017] Example
[0018] (1) Preparation of Yunnan Polygonatum cyrtonema extract: Wash and slice the fresh Yunnan Polygonatum cyrtonema sample, freeze-dry and grind it, and pass it through a 60-mesh sieve. After adding 80% ethanol at a mass ratio of 1:20 between the material and the liquid, ultrasonicate at 60°C for 60 min, filter, take the supernatant, extract the residue repeatedly, combine the filtrate, concentrate under reduced pressure, freeze-dry, and obtain the Yunnan Polygonatum cyrtonema extract, which is stored at low temperature and away from light;
[0019] (2) Preparation of cell-free supernatant: The thermophilic Streptococcus and bulgaricus (1:1) composite strain and Monascus rubrum strain were cultured in culture medium (the composition of the culture medium is shown in the following table) for 48 h, and then the cells were collected by centrifugation, washed three times with phosphate buffered saline (PBS), and resuspended in PBS at a bacterial concentration of 1×10 9 CFU / mL, fungal concentration is 1×10 9 / mL, incubate for 24h. Centrifuge the bacterial suspension (10000rpm, 15min), filter with 0.22μm filter membrane, take the supernatant, and obtain cell-free supernatant (CFS);
[0020] (3) After the preparation of the CFS of the Polygonatum cyrtonema extract solution and the strain was completed, they were mixed in the ratio of 1:1, 1:2, 1:3, 2:1 and 3:1, respectively, and the mixed solution was stored at low temperature for testing.
[0021] Table 1 Composition of culture medium
[0022]
[0023] Test method:
[0024] 1. Determination of Antioxidant Activity in Vitro
[0025] The ABTS cation radical scavenging ability was determined according to the method previously described by Ghimire et al. (Comparative Study on Seed Characteristics, Antioxidant Activity, and Total Phenolic and Flavonoid Contents in Accessions of Sorghum bicolor (L.) Moench), with slight modifications: prepare ABTS working solution (5 mL 7 mmol / L ABTS + 0.088 mL 140 mmol / L potassium persulfate), react in the dark for 12 h, and the absorbance of the diluted working solution at 734 nm was 0.70 ± 0.02 to obtain the ABTS cation radical stock solution. 50 μL of the sample of appropriate concentration was mixed with 200 μL of ABTS cation radical solution, reacted at room temperature in the dark for 5 min, and the absorbance was measured at 734 nm (A1). Methanol replaced the ABTS cation radical solution as the blank group (A0), and 80% ethanol replaced the sample as the control group (A). The determination was repeated three times in parallel, and the scavenging rate was calculated according to the formula.
[0026] The determination of DPPH free radical scavenging ability was based on the method described by Hu et al. (An Evaluation of Traits, Nutritional, and Medicinal Component Quality of Polygonatum cyrtonema Hua and P. sibiricum Red), with some modifications: 100 μL of sample of appropriate concentration was mixed with 100 μL of DPPH free radical solution in a 96-well ELISA plate, reacted at room temperature in the dark for 30 min, and the absorbance was measured at 517 nm (A1). Methanol replaced the DPPH free radical solution as the blank group (A0), and 80% ethanol replaced the sample as the control group (A).
[0027] Use IC 50 It represents the free radical scavenging ability. The scavenging ability calculation formula is as follows:
[0028]
[0029] The determination of ferric ion reducing antioxidant power (FRAP) was based on the method of Li et al. (Potential Antioxidative and Anti-Hyperuricemic Components Targeting Superoxide Dismutase and Xanthine Oxidase Explored from Polygonatum Sibiricum Red): 50 μL of sample of appropriate concentration was mixed with 200 μL FRAP working solution (TPTZ+FeCl3·6H2O+acetic acid buffer) in a 96-well ELISA plate, reacted at 37°C for 10 min, and the absorbance was measured at a wavelength of 593 nm. The absorbance of 10, 20, 40, 60, 80, and 100 μg / mL FeSO4 was determined in the same manner as above, and a standard curve was drawn to obtain the formula y=0.009x+0.0839 (R2=0.9976). The results were expressed in μg Fe 2+ / mg sample.
[0030] 2. In vitro anti-inflammatory and immunomodulatory activity assay
[0031] Sample preparation: The sample to be tested was dissolved in DMEM medium, filtered through 0.22 μm, dissolved in cryotubes at 37°C, centrifuged (1000 rpm, 5 min), washed with PBS, added with culture medium (DMEM+10% FBS+1% penicillin-streptomycin mixture), and cultured in a carbon dioxide incubator (5% CO2, 37°C).
[0032] The cell viability was determined by CCK-8 method (Anti-Inflammatory Activity and Mechanism of Cryptochlorogenic Acid from Ageratina adenophora): the concentration of the cell suspension was diluted to 5×10 4 100 μL was taken and cultured in a 96-well ELISA plate for 24 h. A control well without sample was set up (A a ) and blank control wells without cells (A b ), after the culture is completed, the supernatant is removed, 100 μL of sample solution containing appropriate concentration (A) is added, and the culture is continued for 24 hours. Finally, 10% CCK-8 solution is added, and the culture is continued for 2 hours. The absorbance is measured at 450 nm, and the calculation formula is as follows:
[0033]
[0034] The NO content was determined by the Griess method (Polygonatum kingianum rhizome extract alleviated scollagen antibody-induced arthritis by modulating proinflammatory cytokine production in mice): cells in good condition and in the logarithmic phase were prepared with a concentration of 1×10 5 Take 200 μL of the cell suspension of 100 μg / mL and add it to a 96-well ELISA plate for 24 hours. Remove the supernatant, wash with PBS, add the sample and LPS for 24 hours, centrifuge, and collect the supernatant. Take 50 μL of the supernatant, add 50 μL of GriessI and 50 μL of GriessII, mix thoroughly, and measure the absorbance at 540 nm. Under the same conditions, measure the absorbance when the mass concentration of NaNO2 is 10, 20, 40, 60, 80, and 100 μg / mL, draw a standard curve, and get the formula y=0.0072x+0.0102(R 2 =0.9988), and the results are expressed as NO concentration (μmol / L).
[0035] The phagocytic rate was determined by neutral red staining: 200 μL cell suspension (1×10 5 / mL) for 24h, washed with PBS, added sample and cultured for 24h, discarded the supernatant, washed with PBS, added 100μL 0.1% neutral red dye, cultured for 4h, discarded the supernatant, washed with PBS, added 100μL cell lysis solution, and cultured for 4h and measured the absorbance at 540nm. The formula for calculating the phagocytic rate is:
[0036]
[0037] The experimental group (cell fluid + sample, A) and the blank group (cell fluid + culture medium, A b ).
[0038] Analysis of test results:
[0039] 1. Free radical scavenging ability
[0040] The DPPH free radical scavenging ability of the compound is as follows Figure 1As shown in A. The removal rates of Yunnan Polygonatum, compound bacteria, and red Monascus were 51.79%, 38.80%, and 18.42%, respectively. When Yunnan Polygonatum was mixed with compound bacteria and red Monascus at a ratio of 3:1 and 1:1, the removal rates were 53.43% and 55.36%, respectively, which were higher than those of single Yunnan Polygonatum, compound bacteria, and red Monascus.
[0041] The ABTS cation radical scavenging ability of the compound is as follows Figure 1 As shown in B. The removal rates of Yunnan Polygonatum, compound bacteria, and red Monascus were 91.58%, 80.75%, and 47.43%, respectively. When Yunnan Polygonatum was mixed with compound bacteria and red Monascus at a ratio of 1:3 and 3:1, the removal rates were 91.63% and 94.38%, respectively, which were higher than those of single Yunnan Polygonatum, compound bacteria, and red Monascus.
[0042] 2. In vitro anti-inflammatory and immunomodulatory activity
[0043] Effects of the compound on cellular NO concentration Figure 2 As shown in A. The NO concentration of the blank group (1.29±0.29μmol / L) was lower than that of the LPS group (15.94±0.50μmol / L) (P<0.01), indicating that the modeling was successful. Compared with LPS, the sample can reduce the NO concentration (P<0.01). The NO concentrations of Polygonatum sibiricum, composite bacteria, and red Monascus were 7.88±0.04μmol / L, 6.54±0.53μmol / L, and 11.48±0.04μmol / L, respectively. When Polygonatum sibiricum was compounded with composite bacteria and red Monascus at a ratio of 3:1, the NO concentrations were 1.08±0.06μmol / L and 1.76±0.26μmol / L, respectively, and the inhibition rates were 93.22% and 88.96%, respectively, which were stronger than those of single Polygonatum sibiricum, composite bacteria, and red Monascus.
[0044] Effects of the compound on the phagocytic ability of RAW264.7 cells Figure 2 As shown in B. Compared with the blank group (100%), the sample can promote the phagocytic ability of RAW264.7 cells (P<0.01). The phagocytic rates of Polygonatum yunnanensis, compound bacteria, and Monascus rubrum were 129.52±0.97%, 110.41±1.39%, and 109.52±0.97%, respectively. When Polygonatum yunnanensis was compounded with compound bacteria and Monascus rubrum at a ratio of 3:1 and 2:1, respectively, the phagocytic rates were 142.22±1.16% and 145.31±1.72%, respectively, and their phagocytic ability was enhanced by 42.22% and 45.31%, respectively, which was stronger than that of single Polygonatum yunnanensis, compound bacteria, and Monascus rubrum.
[0045] The technical solution provided by the present invention is introduced in detail above. For those skilled in the art, according to the concept of the embodiments of the present invention, there may be changes in the specific implementation method and application scope. In summary, the content of this specification should not be understood as limiting the present invention.
Claims
1. A method for preparing a postbiotic from Polygonatum dahliae with anti-inflammatory effect, It is characterized in that The preparation steps include: (1) Preparation of Yunnan Polygonatum cyrtonema extract: Wash and slice a fresh Yunnan Polygonatum cyrtonema sample, freeze-dry and grind it, and pass it through a 60-mesh sieve; add the sieved powder into an ethanol aqueous solution, and perform ultrasonic extraction at 60° C. After the extraction is completed, filter the solution, take the supernatant, and repeat the above extraction process with the residue, combine the two filtrates, concentrate under reduced pressure, and freeze-dry to obtain the Yunnan Polygonatum cyrtonema extract, which is stored at 2° C. and away from light; (2) Preparation of cell-free supernatant: After culturing the strain in a culture medium, the bacterial cells are collected by centrifugation, washed 2 to 3 times with a phosphate buffered saline solution, and then resuspended in a phosphate buffered saline solution and incubated; the bacterial suspension is then centrifuged, filtered through a filter membrane, and the supernatant is collected to obtain a cell-free supernatant; (3) The polygonatum cyrtonema extract is compounded with the cell-free supernatant, and the compounded solution is stored at 2° C. to obtain the polygonatum cyrtonema postbiotics.
2. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 1, It is characterized in that In the ethanol aqueous solution, the volume percentage of ethanol is 80%, and the mass ratio of the sieved powder added to the ethanol aqueous solution is sieved powder: ethanol aqueous solution = 1:20 (g:mL).
3. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 1, It is characterized in that Ultrasonic extraction was performed at 60°C for more than 60 min.
4. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 1, It is characterized in that The strain is a 1:1 composite strain of thermophilic streptococcus and bulgaricus lactobacillus, or a red monascus strain.
5. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 1, It is characterized in that The concentration of bacteria resuspended in phosphate buffered saline is: bacterial concentration is 1×10 9 CFU / mL, fungal concentration is 1×10 9 / mL; incubate for 24h.
6. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 1, It is characterized in that Filter using a 0.22 μm filter membrane.
7. The method for preparing the Yunnan Polygonatum postbiotics with anti-inflammatory effect according to claim 4, It is characterized in that The compounding ratio of the polygonatum sibiricum extract and the cell-free supernatant is: the polygonatum sibiricum extract and the cell-free supernatant of the culture of thermophilic Streptococcus and Lactobacillus bulgaricus are compounded in a volume ratio of polygonatum sibiricum extract:cell-free supernatant=3:1; the polygonatum sibiricum extract and the cell-free supernatant of the culture of Monascus ruber are compounded in a volume ratio of polygonatum sibiricum extract:cell-free supernatant=2:1.
Citation Information
Patent Citations
Immunity-enhancing metagen compound and preparation method thereof
CN115040605A
Streptococcus thermophilus and application
CN118460430A
A stable and safe microecological formulation, its preparation and usage
CN1663573A
Cited By
Marker and method for distinguishing processing modes of malania oleifera oil
CN119147710A
Markers and methods for distinguishing garlic fruit oil processing methods
CN119147710B
